SP acts by inhibiting the folic acid synthesis in the malaria parasite; sulfadoxine and pyrimethamine inhibit the Plasmodium falciparum enzymes dihydropteroate synthetase (DHPS) and dihydrofolate reductase (DHFR), respectively [7, 8]. Here, DHFR is linked to malaria.